Protective HIV-specific CD8+ T cells evade T reg cell suppression

Viral Vaccine Program, Seattle Biomedical Research Institute (Seattle Biomed), Seattle, Washington, USA.
Nature medicine (Impact Factor: 27.36). 07/2011; 17(8):989-95. DOI: 10.1038/nm.2422
Source: PubMed


Specific human leukocyte antigens (HLAs), notably HLA-B*27 and HLA-B*57 allele groups, have long been associated with control of HIV-1. Although the majority of HIV-specific CD8(+) T cells lose proliferative capacity during chronic infection, T cells restricted by HLA-B*27 or HLA-B*57 allele groups do not. Here we show that CD8(+) T cells restricted by 'protective' HLA allele groups are not suppressed by T(reg) cells, whereas, within the same individual, T cells restricted by 'nonprotective' alleles are highly suppressed ex vivo. This differential sensitivity of HIV-specific CD8(+) T cells to T(reg) cell-mediated suppression correlates with their expression of the inhibitory receptor T cell immunoglobulin domain and mucin domain 3 (Tim-3) after stimulation with their cognate epitopes. Furthermore, we show that HLA-B*27- and HLA-B*57-restricted effectors also evade T(reg) cell-mediated suppression by directly killing T(reg) cells they encounter in a granzyme B (GzmB)-dependent manner. This study uncovers a previously unknown explanation for why HLA-B*27 and HLA-B*57 allele groups are associated with delayed HIV-1 disease progression.

Download full-text


Available from: David M Koelle
  • Source
    • "Thirdly, H. Benham et al. / Best Practice & Research Clinical Rheumatology xxx (2015) 1e13 7 Please cite this article in press as: Benham H, et al., Role of genetics in infection-associated arthritis, Best Practice & Research Clinical Rheumatology (2015), CD8þ T cells from HLA-B27 patients are more likely to escape regulatory T cell suppression, and may therefore display sustained cytotoxicity [71]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Genetic discoveries in arthritis and their associated biological pathways spanning the innate and adaptive immune system demonstrate the strong association between susceptibility to arthritis and control of exogenous organisms. The canonical theory of the aetiology of immune-mediated arthritis and other immune-mediated diseases is that the introduction of exogenous antigenic stimuli to a genetically susceptible host sets up the environment for an abnormal immune response manifesting as disease. A disruption in host-microbe homeostasis driven by disease-associated genetic variants could ultimately provide the source of exogenous antigen triggering disease development. We discuss genetic variants impacting the innate and adaptive arms of the immune system and their relationship to microbial control and arthritic disease. We go on to consider the evidence for a relationship between HLA-B27, infection and arthritis, and then emerging evidence for an interaction between microbiota and rheumatoid arthritis.
    Full-text · Article · Apr 2015 · Best practice & research. Clinical rheumatology
  • Source
    • "Together, these data suggest that Treg are globally functional, although the magnitude of their effect is not consistent across all cellular functions. Such differential suppression had already been reported by Elahi et al, as Treg had a more marked effect on CD8 cytokine production than on proliferation [41]. Because upregulation of CTLA-4 and PD-1 are associated with increased suppressive capacity of Treg [42], we also characterized the expression of these molecules by Treg. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the effect of late initiation of HAART and poor immune reconstitution on the frequency of regulatory T-cells (Treg) in the peripheral blood and gut of HIV-infected patients, we studied Colombian HIV-infected patients who had been on suppressive HAART for at least one year. They had undetectable viremia but were either immunological responders (HIR); (CD4 counts >500 cells/µl) or non-immunological responders (NIR); (CD4 T-cell count <300 cells/µl). Untreated HIV-infected patients and uninfected controls from the same region were also evaluated. Frequency and phenotype of regulatory T-cells (Treg) were analyzed in gut biopsies and blood samples. The functional effect of Treg depletion on CMV and HIV responses was determined. Markers of immune activation and circulating LPS levels were quantified. Untreated patients exhibited high Treg frequency in PBMC and gut, and their Treg express high levels of CTLA-4 and PD-1. Although HAART significantly decreased mucosal Treg frequency, it did not normalize it in any of the treated groups (HIR and NIR patients). Treg normalization was observed in the blood of HIR patients following HAART, but did not occur in NIR patients. Treg from HIV-infected patients (treated or not) suppressed HIV and hCMV-specific T-cells from gut and blood. Plasma LPS levels and percentage of HLA-DR+CD38+ T-cells were significantly elevated in all infected groups compared to controls. These findings suggest that control of viral replication is not sufficient to normalize gut Treg frequency in patients, independent of their response to HAART. Furthermore, persistence of functional Treg in the gut appears to be associated with the failure of HAART to repair mucosal damage.
    Full-text · Article · Aug 2013 · PLoS ONE
  • Source
    • "HLA-B*5701 was previously associated with low viremia and delayed onset of AIDS through candidate gene studies (Stephens, 2005). The potential function of this allele has been widely explored: notably, the presentation of specific HIV-1 epitopes able to initiate a strong cytotoxic T-lymphocyte response, and the TCR clonotype recognizing the HLA-peptide complex were largely emphasized (Klein et al., 1998; Migueles et al., 2000; Gillespie et al., 2002, 2006; Miura et al., 2009; Elahi et al., 2011; Chen et al., 2012; Kloverpris et al., 2012). Following this path, the international HIV controllers study confirmed the overwhelming importance of HLA alleles for viral control (B*5701, B*2705, B*14/C*0802, B*52, and A*25 as protective alleles, and B*35 and C*07 as risk alleles) and identified putative causal variants in the HLA-B peptide-binding groove (including residues at position 67, 70, and 97) in Europeans (International HIV Controllers Study et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Very early after the identification of the human immunodeficiency virus (HIV), host genetics factors were anticipated to play a role in viral control and disease progression. As early as the mid-1990s, candidate gene studies demonstrated a central role for the chemokine co-receptor/ligand (e.g., CCR5) and human leukocyte antigen (HLA) systems. In the last decade, the advent of genome-wide arrays opened a new era for unbiased genetic exploration of the genome and brought big expectations for the identification of new unexpected genes and pathways involved in HIV/AIDS. More than 15 genome-wide association studies targeting various HIV-linked phenotypes have been published since 2007. Surprisingly, only the two HIV-chemokine co-receptors and HLA loci have exhibited consistent and reproducible statistically significant genetic associations. In this chapter, we will review the findings from the genome-wide studies focusing especially on non-progressive and HIV control phenotypes, and discuss the current perspectives.
    Full-text · Article · May 2013 · Frontiers in Immunology
Show more